Who owns Lumos Pharma Inc?
- Ticker: LUMO
- CUSIP Number: 55028x109
Tip: Access positions for across all investors
Analyze quarterly positions in Lumos Pharma with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Lumos Pharma stock
Who bought or sold Lumos Pharma Inc this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Wells Fargo & Company | 416k | $1.2M | 0% | Mar 2024 |
|
| Goldman Sachs Group | 407k | $1.1M | 0% | Mar 2024 |
|
| Vanguard Group | 244k | $688k | 0% | Mar 2024 |
|
| Acuitas Investments | 141k | $397k | 12% | Mar 2024 |
|
| Leucadia National Corporation | 121k | $340k | 0% | Mar 2024 |
|
| Lion Point Capital | 91k | $256k | 0% | Mar 2024 |
|
| Blackstone Group | 79k | $222k | -76% | Mar 2024 |
|
| Greenwich Wealth Management | 76k | $215k | 0% | Mar 2024 |
|
| Geode Capital Management | 48k | $134k | 0% | Mar 2024 |
|
| BlackRock | 41k | $116k | -5% | Mar 2024 |
|
| Two Sigma Investments | 39k | $110k | -9% | Mar 2024 |
|
| Millennium Management | 38k | $106k | 100% | Mar 2024 |
|
| Two Sigma Advisers | 32k | $90k | 13% | Mar 2024 |
|
| Dimensional Fund Advisors | 30k | $84k | 90% | Mar 2024 |
|
| Bridgeway Capital Management | 28k | $78k | -42% | Mar 2024 |
|
| Marquette Asset Management | 26k | $73k | 0% | Mar 2024 |
|
| Envestnet Asset Management | 16k | $45k | 41% | Mar 2024 |
|
| Private Advisor | 16k | $45k | 0% | Mar 2024 |
|
| Citadel Advisors | 13k | $38k | 100% | Mar 2024 |
|
| Bank of New York Mellon | 12k | $33k | 0% | Mar 2024 |
|
| Wealth Advisors of Iowa | 12k | $33k | 0% | Mar 2024 |
|
| Key FInancial | 11k | $31k | 0% | Mar 2024 |
|
| Paladin Advisory Group | 4.4k | $13k | 0% | Mar 2024 |
|
| UBS Group | 3.7k | $11k | 4945% | Mar 2024 |
|
| Tower Research Capital | 2.7k | $7.6k | 39% | Mar 2024 |
|
| Bank of America Corporation | 1.8k | $5.1k | 0% | Mar 2024 |
|
| West Financial Advisors | 784.00 | $2.2k | 0% | Mar 2024 |
|
| Morgan Stanley | 166.00 | $468.003800 | 36% | Mar 2024 |
|
| Advisor Group Holdings | 154.00 | $435.404200 | -97% | Mar 2024 |
|
| Group One Trading | 150.00 | $423.000000 | 0% | Mar 2024 |
|
| Royal Bank of Canada | 78.00 | $0 | 0% | Mar 2024 |
|
| Jpmorgan Chase & Co | 41.00 | $116.001300 | 8% | Mar 2024 |
|
| Live Oak Investment Partners | 11.00 | $34.999800 | 0% | Dec 2023 |
|
| Global Retirement Partners | 11.00 | $31.000200 | 0% | Mar 2024 |
|
| Qube Research & Technologies | 3.00 | $8.000100 | 0% | Mar 2024 |
|
Who sold out of Lumos Pharma?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Cypress Capital Management | Dec 2023 | 100.00 | $318.000000 |
| Northwestern Mutual Wealth Management Company | Sep 2023 | 41.00 | $135.000700 |